Our GLP-1 capsules are formulated with Eriomin, a clinically-studied ingredient that harnesses the potential of lemon flavonoids to support healthy GLP-1 function
They are generally not recommended for patients with a personal or family history of medullary thyroid cancer or Multiple Endocrine Neoplasia syndrome type 2 (MEN2), those who are pregnant or breastfeeding or planning pregnancy, patients with a known allergy to the medication, severe gastroparesis or serious digestive motility disorders, active pancreatitis or significant pancreatitis history, serious gallbladder disease, certain kidney conditions, or active eating disorder concerns
Recent Developments: Initiated Phase 3 trials for maritide (caftaglutide), targeting both GLP-1 and GIP receptors
The postbiotic supports the machinery
Significant reductions in HbA1c and fasting glucose were observed in adults with obesity type 2 diabetes, outperforming monotherapies
Two findings carry the most weight for the bodybuilding discussion